id: NEW:transoral_robotic_surgery_salvage_to_NEW:surgical_morbidity_mortality
name: Transoral Robotic Surgery for Salvage Treatment â†’ Surgical Morbidity and Mortality
from_node:
  node_id: NEW:transoral_robotic_surgery_salvage
  node_name: Transoral Robotic Surgery for Salvage Treatment
to_node:
  node_id: NEW:surgical_morbidity_mortality
  node_name: Surgical Morbidity and Mortality
direction: negative
category: healthcare_access
mechanism_pathway:
- 'Step 1: Transoral robotic surgery (TORS) provides a minimally invasive approach
  for salvage treatment of recurrent, residual, or second primary head and neck cancers
  in previously irradiated fields'
- 'Step 2: The robotic approach avoids the extensive tissue dissection and reconstruction
  required in traditional open surgical techniques, reducing surgical trauma'
- 'Step 3: Reduced surgical invasiveness leads to shorter hospital stays (mean 8.5
  days), faster tracheostomy decannulation (9.7 days), and reduced nasogastric dependence
  (12.8 days)'
- 'Step 4: Pooled complication rate of 32.3% with 92% of complications being low-grade
  (Clavien Dindo grade 2 or 3), indicating manageable morbidity'
- 'Step 5: Long-term tracheostomy dependence occurs in only 0%-11.5% of patients,
  demonstrating favorable functional preservation compared to open techniques'
evidence:
  quality_rating: A
  n_studies: 15
  primary_citation: 'Sahil Goel et al. 2025. Is transoral robotic surgery useful as
    a salvage technique in head and neck cancers: a systematic review and meta analysis.
    Head & neck.'
  supporting_citations: []
description: Transoral robotic surgery for salvage treatment of recurrent/residual
  head and neck cancers demonstrates decreased morbidity and mortality compared to
  traditional open surgical techniques. This systematic review of 15 studies (515
  patients) found TORS achieves favorable oncological outcomes (2-year OS 73.8%, DFS
  56.1%) with manageable complications (32.3% pooled rate, mostly low-grade). The
  minimally invasive approach reduces tracheostomy and feeding tube dependence, preserving
  function while treating cancer in previously irradiated tissue.
last_updated: '2025-12-02'
extraction_method: consolidated_batch_v3
quantitative_effects:
  effect_size:
    value: 0.35
    type: risk_ratio
    ci_lower: 0.18
    ci_upper: 0.67
  p_value: null
  sample_size: 515
moderators:
- name: HPV status
  direction: strengthens
  strength: moderate
  description: HPV-positive tumors may have better outcomes; identified as a confounding
    factor requiring future study
- name: Prior adjuvant therapy
  direction: weakens
  strength: moderate
  description: Previous radiation treatment in the surgical field may impact outcomes
    and complications
- name: Tumor site
  direction: strengthens
  strength: moderate
  description: Oropharyngeal tumors most amenable to TORS approach
